Home/Pipeline/Genitourinary Cancer Consortium

Genitourinary Cancer Consortium

Prostate, Bladder, and other GU Cancers

UnknownActive

Key Facts

Indication
Prostate, Bladder, and other GU Cancers
Phase
Unknown
Status
Active
Company

About Criterium

Criterium is a long-established, privately-held CRO that has carved out a specialized niche in oncology clinical research through its innovative Oncology Consortia model. The company combines hands-on operational expertise with technology solutions like interactive voice/web response (IVR/IWR) and ePRO to manage complex trials efficiently. Its core strategy involves forming disease-specific consortia with top-tier universities and cancer centers, enabling rapid patient recruitment and high-quality data generation for pharmaceutical and biotech sponsors. While primarily a service provider, its deep integration into therapeutic development gives it significant insight into the oncology pipeline landscape.

View full company profile